Seoul Pharma Co., Ltd (KOSDAQ:018680)
2,945.00
+5.00 (0.17%)
At close: Jan 23, 2026
Seoul Pharma Market Cap
Seoul Pharma has a market cap or net worth of 34.34 billion as of January 23, 2026. Its market cap has decreased by -13.38% in one year.
Market Cap
34.34B
Enterprise Value
44.52B
Revenue
52.43B
Ranking
n/a
PE Ratio
19.18
Stock Price
2,945.00
Market Cap Chart
Since March 1, 2001, Seoul Pharma's market cap has increased from 20.00B to 34.34B, an increase of 71.68%. That is a compound annual growth rate of 2.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 34.34B | -4.38% |
| Dec 30, 2025 | 35.91B | -6.95% |
| Dec 30, 2024 | 38.59B | -13.58% |
| Dec 28, 2023 | 44.66B | -23.86% |
| Dec 29, 2022 | 58.65B | -12.36% |
| Dec 30, 2021 | 66.92B | -28.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyung Nam Pharm | 48.61B |
| Korean Drug | 45.39B |
| HLscience | 40.13B |
| GeneBioTech Co. ,Ltd | 36.64B |
| ChoA Pharmaceutical Co., LTD. | 27.91B |
| Daesung Microbiological Labs. | 26.83B |
| Pharmsville | 26.43B |
| BL Pharmtech | 25.91B |